From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 3057
Publisher
MDPI AG
Online
2020-10-21
DOI
10.3390/cancers12103057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combination therapy with oncolytic viruses and immune checkpoint inhibitors
- (2020) Matthew Chiu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Chimeric oncolytic Ad5/3 virus replicates and lyses ovarian cancer cells through desmoglein‐2 cell entry receptor
- (2020) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions
- (2020) Cecilia A. Larocca et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Tumor infiltrating lymphocytes: The regulator of melanoma evolution (Review)
- (2019) Mihaela Antohe et al. Oncology Letters
- Targeting immune cells for cancer therapy
- (2019) Sin Yee Gun et al. Redox Biology
- Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks
- (2019) Lukasz Kuryk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Abscopal effect when combining oncolytic adenovirus and checkpoint inhibitor in a humanized NOG mouse model of melanoma
- (2019) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Long-Term Survival, Quality of Life, and Psychosocial Outcomes in Advanced Melanoma Patients Treated with Immune Checkpoint Inhibitors
- (2019) Anne Rogiers et al. Journal of Oncology
- Oncolytic Viruses: Priming Time for Cancer Immunotherapy
- (2019) Luke Russell et al. BIODRUGS
- Advances in cancer immunotherapy 2019 – latest trends
- (2019) Stephan Kruger et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Optimizing oncolytic virotherapy in cancer treatment
- (2019) Kevin Harrington et al. NATURE REVIEWS DRUG DISCOVERY
- Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds
- (2019) Venkatesh Sivanandam et al. Molecular Therapy-Oncolytics
- Tumor neoantigens: from basic research to clinical applications
- (2019) Tao Jiang et al. Journal of Hematology & Oncology
- Neoantigen vaccine: an emerging tumor immunotherapy
- (2019) Miao Peng et al. Molecular Cancer
- Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
- (2019) Antonio Marchini et al. Frontiers in Immunology
- Development of a new fusion-enhanced oncolytic immunotherapy platform based on herpes simplex virus type 1
- (2019) Suzanne Thomas et al. Journal for ImmunoTherapy of Cancer
- Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
- (2019) Shixiang Wang et al. eLife
- Basis of PD1/PD-L1 Therapies
- (2019) Barbara Seliger Journal of Clinical Medicine
- Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
- (2018) Roberta Zappasodi et al. CANCER CELL
- Quantification and functional evaluation of CD40L production from the adenovirus vector ONCOS-401
- (2018) Lukasz Kuryk et al. CANCER GENE THERAPY
- BRAF and MEK Inhibitors: Use and Resistance in BRAF-Mutated Cancers
- (2018) Jaquelyn N. Sanchez et al. DRUGS
- Cutaneous melanoma: From pathogenesis to therapy (Review)
- (2018) Giulia Leonardi et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
- (2018) M. Garofalo et al. JOURNAL OF CONTROLLED RELEASE
- Hitting the Target: How T Cells Detect and Eliminate Tumors
- (2018) Anthony E. Zamora et al. JOURNAL OF IMMUNOLOGY
- Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model
- (2018) Lukasz Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Potential clinical and immunotherapeutic utility of talimogene laherparepvec for patients with melanoma after disease progression on immune checkpoint inhibitors and BRAF inhibitors
- (2018) Jason Chesney et al. MELANOMA RESEARCH
- Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients
- (2018) Michael Constantin Kirchberger et al. Oncotarget
- Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer
- (2018) Giulia Marelli et al. Frontiers in Immunology
- Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
- (2018) Aurélie Durgeau et al. Frontiers in Immunology
- TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
- (2018) V. Cervera-Carrascon et al. OncoImmunology
- Talimogene Laherparepvec combined with anti-PD-1 based immunotherapy for unresectable stage III-IV melanoma: a case series
- (2018) Lillian Sun et al. Journal for ImmunoTherapy of Cancer
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Therapeutically active RIG-I agonist induces immunogenic tumor cell killing in breast cancers
- (2018) David L Elion et al. CANCER RESEARCH
- Melanoma treatment: from conventional to nanotechnology
- (2018) Harshita Mishra et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice
- (2018) M. Garofalo et al. JOURNAL OF CONTROLLED RELEASE
- Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies
- (2018) Mariangela Garofalo et al. Viruses-Basel
- Combination of immunogenic oncolytic adenovirus ONCOS-102 with anti-PD-1 pembrolizumab exhibits synergistic antitumor effect in humanized A2058 melanoma huNOG mouse model
- (2018) Lukasz Kuryk et al. OncoImmunology
- Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
- (2017) Lisa Zimmer et al. EUROPEAN JOURNAL OF CANCER
- Pembrolizumab Utilization and Outcomes for Advanced Melanoma in US Community Oncology Practices
- (2017) C. Lance Cowey et al. JOURNAL OF IMMUNOTHERAPY
- Melanoma subtypes demonstrate distinct PD-L1 expression profiles
- (2017) Genevieve J Kaunitz et al. LABORATORY INVESTIGATION
- Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine
- (2017) Liang Cheng et al. MODERN PATHOLOGY
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of Treatment‐Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma
- (2017) Adil Daud et al. ONCOLOGIST
- Tuning cancer fate: the unremitting role of host immunity
- (2017) B. Calì et al. Open Biology
- A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma
- (2017) Cristian Capasso et al. OncoImmunology
- Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies
- (2017) Sachin R. Jhawar et al. Frontiers in Oncology
- Biomarkers for Response of Melanoma Patients to Immune Checkpoint Inhibitors: A Systematic Review
- (2017) Charissa A. C. Jessurun et al. Frontiers in Oncology
- Melanoma
- (2017) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102 – Support for clinical studies on advanced cancer treatment
- (2017) Lukasz Kuryk et al. PLoS One
- Innate immune signaling and regulation in cancer immunotherapy
- (2016) Leticia Corrales et al. CELL RESEARCH
- Pembrolizumab: A Review in Advanced Melanoma
- (2016) Emma D. Deeks DRUGS
- Treatment patterns of advanced malignant melanoma (stage III–IV) – A review of current standards in Europe
- (2016) Mark Harries et al. EUROPEAN JOURNAL OF CANCER
- Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model
- (2016) Lukasz Kuryk et al. INTERNATIONAL JOURNAL OF CANCER
- Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
- (2016) Daniel G. Coit et al. Journal of the National Comprehensive Cancer Network
- Application potential of toll-like receptors in cancer immunotherapy
- (2016) Ming Shi et al. MEDICINE
- Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity
- (2016) M. Garofalo et al. MOLECULAR CANCER THERAPEUTICS
- Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management
- (2016) Paola Savoia et al. Human Vaccines & Immunotherapeutics
- The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
- (2016) Pankita H. Pandya et al. Journal of Immunology Research
- Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
- (2016) Mari Hirvinen et al. Molecular Therapy-Oncolytics
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- The Safety and Efficacy of Narrow Band Ultraviolet B Treatment in Dermatology: A Review
- (2015) Anna Sokolova et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype
- (2015) Nicholas L. Berlin et al. Cancer Epidemiology
- Five-Year Survival Rates for Treatment-Naive Patients With Advanced Melanoma Who Received Ipilimumab Plus Dacarbazine in a Phase III Trial
- (2015) Michele Maio et al. JOURNAL OF CLINICAL ONCOLOGY
- Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses
- (2015) Norman Woller et al. MOLECULAR THERAPY
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Environmental Surveillance of Non-polio Enteroviruses in Poland, 2011
- (2015) Magdalena Wieczorek et al. Food and Environmental Virology
- Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment
- (2015) Mariana Aris et al. Frontiers in Immunology
- Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
- (2015) Cristian Capasso et al. OncoImmunology
- Phase II calm extension study: Coxsackievirus A21 delivered intratumorally to patients with advanced melanoma induces immune-cell infiltration in the tumor microenvironment
- (2015) Robert HI Andtbacka et al. Journal for ImmunoTherapy of Cancer
- The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
- (2014) Boris C. Bastian Annual Review of Pathology-Mechanisms of Disease
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Host Immune Response to Infection and Cancer: Unexpected Commonalities
- (2014) Romina S. Goldszmid et al. Cell Host & Microbe
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns in melanocytic lesions: impact of the geometry on growth and transport inside the epidermis
- (2014) T. Balois et al. Journal of the Royal Society Interface
- Systemic treatment for BRAF-mutant melanoma: where do we go next?
- (2014) Alexander M Menzies et al. LANCET ONCOLOGY
- Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study
- (2014) Antoni Ribas et al. LANCET ONCOLOGY
- Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
- (2014) D. Zamarin et al. Science Translational Medicine
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer
- (2014) Andrew Nguyen et al. Frontiers in Oncology
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- T-cell tolerance in cancer
- (2013) Roza Nurieva et al. Immunotherapy
- Immune system: a double-edged sword in cancer
- (2013) Bodduluru Lakshmi Narendra et al. INFLAMMATION RESEARCH
- Genetic analysis of poliovirus strains isolated from sewage in Poland
- (2013) Ł. Kuryk et al. JOURNAL OF MEDICAL VIROLOGY
- Targeting Mutant BRAF in Melanoma
- (2012) Ragini Kudchadkar et al. CANCER JOURNAL
- Vemurafenib in Patients With BRAF V600E Mutation–Positive Advanced Melanoma
- (2012) Marcus C. Ravnan et al. CLINICAL THERAPEUTICS
- Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
- (2012) Axel Hauschild et al. LANCET
- Oncolytic adenoviruses
- (2012) Vincenzo Cerullo et al. OncoImmunology
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation and immune surveillance in cancer
- (2011) Melvyn T. Chow et al. SEMINARS IN CANCER BIOLOGY
- Dual E1A oncolytic adenovirus: targeting tumor heterogeneity with two independent cancer-specific promoter elements, DF3/MUC1 and hTERT
- (2010) J C Doloff et al. CANCER GENE THERAPY
- Oncolytic Adenoviruses for the Treatment of Human Cancer: Focus on Translational and Clinical Data
- (2010) Sari Pesonen et al. MOLECULAR PHARMACEUTICS
- Melanocytes in development and cancer
- (2009) Audrey Uong et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started